Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 3.48B | 3.37B | 3.05B | 4.04B | 8.32B |
Gross Profit | 1.20B | 1.21B | 1.07B | 1.28B | 1.28B |
EBITDA | 89.21M | 252.33M | -632.67M | 236.29M | 402.56M |
Net Income | 62.94M | 91.11M | -702.35M | 121.55M | 303.19M |
Balance Sheet | |||||
Total Assets | 3.77B | 3.66B | 3.45B | 4.40B | 4.47B |
Cash, Cash Equivalents and Short-Term Investments | 494.58M | 976.65M | 693.23M | 1.24B | 990.90M |
Total Debt | 842.03M | 682.31M | 636.85M | 1.02B | 901.21M |
Total Liabilities | 2.15B | 2.14B | 2.03B | 2.26B | 2.43B |
Stockholders Equity | 1.62B | 1.52B | 1.42B | 2.14B | 2.04B |
Cash Flow | |||||
Free Cash Flow | -855.68M | 193.67M | -162.41M | 66.89M | 168.58M |
Operating Cash Flow | -594.29M | 219.59M | -160.24M | 217.31M | 207.46M |
Investing Cash Flow | -47.51M | 186.39M | -51.82M | -92.97M | -98.23M |
Financing Cash Flow | 159.72M | 35.43M | -383.14M | 98.70M | -129.19M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
83 Outperform | ¥5.38B | 6.15 | 3.03% | 0.55% | 21.35% | ||
74 Outperform | ¥54.21B | 13.51 | 2.90% | 6.66% | -34.82% | ||
73 Outperform | ¥3.42B | 8.28 | 1.62% | -10.20% | -6.44% | ||
71 Outperform | ¥13.09B | 10.36 | 3.58% | -6.96% | -1.72% | ||
58 Neutral | HK$14.11B | 4.63 | -3.01% | 6.76% | 3.67% | -54.16% | |
55 Neutral | ¥1.64B | 36.23 | ― | 5.81% | -67.86% | ||
50 Neutral | ¥2.06B | ― | 2.78% | -37.17% | -1132.44% |